We provide you with 20 years of free, institutional-grade data for LIXT stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of LIXT. Explore the full financial landscape of LIXT stock.
| Reported Date | CIK | Ticker | Type |
|---|
Lixte Biotechnology(NASDAQ:LIXT) 
Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are use...
Share this website to your friends
The information provided in this report about LIXT stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.